SENEXON-S

Product NDC: 33261-749
11-digit product format: 332610749
Labeler code: 33261
Product ID: 33261-749_99e011cc-0e61-4ecd-87c7-04d397ee15e6
Type: HUMAN OTC DRUG
Nonproprietary name: DOCUSATE SODIUM -SENNOSIDES
Dosage form: TABLET, COATED
Route: ORAL
Labeler: Aidarex Pharmaceuticals LLC
Application: part334
Marketing category: OTC MONOGRAPH NOT FINAL
Marketing start: 2011-03-16
Marketing end: 0000-00-00
Substance: DOCUSATE SODIUM; SENNOSIDES A AND B
Active strength: 50 mg/1; mg/1
NDC exclude flag: No
Listing certified through: 2019-12-31
Current FDA listing: Historical FDA.report record

NDC auxiliary status#

These records are reproduced from FDA’s unfinished, excluded, and compounder listings. They describe what appeared in the source files; a missing record does not establish a regulatory status. View all current auxiliary records, including entries without an NDC. · View the auxiliary file history.

Current NDC status page 1 of 1 · 2 matching rows.

Dataset, Scope, Product NDC table
Dataset	Scope	Product NDC	Package NDC	Code	Status	Reporting period	Source date
excluded product	product	33261-749		I	Inactivated by FDA		2026-10-16
excluded package	package	33261-749	33261-749-00	I	Inactivated by FDA		2026-10-16

Observed NDC auxiliary status history#

This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.

Historic NDC status page 1 of 1 · 42 matching rows.

View current auxiliary records. · View the auxiliary file history.

Captured / source date, Dataset, Scope table
Captured / source date	Dataset	Scope	Package NDC	Snapshot	Source SHA-256
2025-12-14 17:58 UTC · source 2025-12-05	excluded product	product		`d630ba8d3edf…`	`732f749b63fb…`
2025-12-14 17:58 UTC · source 2025-12-05	excluded package	package	33261-749-00	`d630ba8d3edf…`	`732f749b63fb…`
2025-08-27 00:01 UTC · source 2025-08-26	excluded product	product		`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-08-27 00:01 UTC · source 2025-08-26	excluded package	package	33261-749-00	`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-04-01 02:39 UTC · source 2025-03-31	excluded product	product		`2ef7874e63bc…`	`57b86245f4fa…`
2025-04-01 02:39 UTC · source 2025-03-31	excluded package	package	33261-749-00	`2ef7874e63bc…`	`57b86245f4fa…`
2025-03-28 20:22 UTC · source 2025-03-28	excluded product	product		`a1b67e2a42f9…`	`c4cf2c586c0d…`
2025-03-28 20:22 UTC · source 2025-03-28	excluded package	package	33261-749-00	`a1b67e2a42f9…`	`c4cf2c586c0d…`
2025-03-22 03:12 UTC · source 2025-03-21	excluded product	product		`cfe11265f3b6…`	`090c488252e2…`
2025-03-22 03:12 UTC · source 2025-03-21	excluded package	package	33261-749-00	`cfe11265f3b6…`	`090c488252e2…`
2025-03-10 12:48 UTC · source 2025-03-10	excluded product	product		`cdf11ea48f46…`	`ba0047e9e063…`
2025-03-10 12:48 UTC · source 2025-03-10	excluded package	package	33261-749-00	`cdf11ea48f46…`	`ba0047e9e063…`
2025-02-02 03:52 UTC · source 2025-01-31	excluded product	product		`302b2466d912…`	`e7b80fea0513…`
2025-02-02 03:52 UTC · source 2025-01-31	excluded package	package	33261-749-00	`302b2466d912…`	`e7b80fea0513…`
2025-01-20 13:05 UTC · source 2025-01-20	excluded product	product		`ed331223b511…`	`672a5bd82f5f…`
2025-01-20 13:05 UTC · source 2025-01-20	excluded package	package	33261-749-00	`ed331223b511…`	`672a5bd82f5f…`
2025-01-11 03:41 UTC · source 2025-01-10	excluded product	product		`0efc9e666f02…`	`f202fb6c5f17…`
2025-01-11 03:41 UTC · source 2025-01-10	excluded package	package	33261-749-00	`0efc9e666f02…`	`f202fb6c5f17…`
2024-11-09 02:27 UTC · source 2024-11-08	excluded product	product		`ad56d346431e…`	`cc804d4bbf1e…`
2024-11-09 02:27 UTC · source 2024-11-08	excluded package	package	33261-749-00	`ad56d346431e…`	`cc804d4bbf1e…`
2024-10-04 04:10 UTC · source 2024-10-03	excluded product	product		`367a005e9d99…`	`383a685ebd0f…`
2024-10-04 04:10 UTC · source 2024-10-03	excluded package	package	33261-749-00	`367a005e9d99…`	`383a685ebd0f…`
2024-07-10 04:00 UTC · source 2024-07-09	excluded product	product		`557ba5c1ecfa…`	`9c80585c8c6e…`
2024-07-10 04:00 UTC · source 2024-07-09	excluded package	package	33261-749-00	`557ba5c1ecfa…`	`9c80585c8c6e…`
2024-05-28 21:12 UTC · source 2024-05-28	excluded product	product		`8af77b9d5b6f…`	`d9bbb34c5368…`
2024-05-28 21:12 UTC · source 2024-05-28	excluded package	package	33261-749-00	`8af77b9d5b6f…`	`d9bbb34c5368…`
2024-05-15 03:39 UTC · source 2024-05-14	excluded product	product		`834df4deac94…`	`adcc014656a3…`
2024-05-15 03:39 UTC · source 2024-05-14	excluded package	package	33261-749-00	`834df4deac94…`	`adcc014656a3…`
2024-03-11 06:39 UTC · source 2024-03-08	excluded product	product		`1332a3947898…`	`d4bfe170f9cd…`
2024-03-11 06:39 UTC · source 2024-03-08	excluded package	package	33261-749-00	`1332a3947898…`	`d4bfe170f9cd…`
2022-08-30 03:57 UTC · source 2022-08-29	excluded product	product		`fb8cb913e6d1…`	`eb8c232b6be0…`
2022-08-30 03:57 UTC · source 2022-08-29	excluded package	package	33261-749-00	`fb8cb913e6d1…`	`eb8c232b6be0…`
2022-04-09 23:13 UTC · source 2022-04-08	excluded product	product		`86f5da6cb304…`	`a595104c45d7…`
2022-04-09 23:13 UTC · source 2022-04-08	excluded package	package	33261-749-00	`86f5da6cb304…`	`a595104c45d7…`
2022-04-04 05:40 UTC · source 2022-04-01	excluded product	product		`bd6a592717d7…`	`303034d00443…`
2022-04-04 05:40 UTC · source 2022-04-01	excluded package	package	33261-749-00	`bd6a592717d7…`	`303034d00443…`
2021-12-27 23:28 UTC · source 2021-12-27	excluded product	product		`8dfbde2a14a4…`	`c9ff85d89658…`
2021-12-27 23:28 UTC · source 2021-12-27	excluded package	package	33261-749-00	`8dfbde2a14a4…`	`c9ff85d89658…`
2020-12-18 03:04 UTC · source 2020-12-17	excluded product	product		`e2bbac7714bc…`	`27bdfed8d636…`
2020-12-18 03:04 UTC · source 2020-12-17	excluded package	package	33261-749-00	`e2bbac7714bc…`	`27bdfed8d636…`
2020-06-10 20:45 UTC · source 2020-06-10	excluded product	product		`9bebd1f3094a…`	`5416666fcb17…`
2020-06-10 20:45 UTC · source 2020-06-10	excluded package	package	33261-749-00	`9bebd1f3094a…`	`5416666fcb17…`

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

FDA-Initiated Inactive NDC Indexing#

NDC, Effective, Action table
NDC	Effective	Action	Document	Indexing SPL	Related label
33261-749-00	2020-01-31	C162847	48780-1	9d75b9d0-fa69-f424-e053-dadaa90a57ce	DOCUSATE SOD SENNA 50 8 6MG FOR RUGBY

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDC	Product	Description	Form	Quantity	Strength	SPL version
33261-749-00	SENEXON-S	100 in 1 BOTTLE, PLASTIC	TABLET, COATED	100		1

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDC	Billing unit	Product NDC	DailyMed indexing SPL	SPL version	Effective
33261-749-00	EA - Each	33261-749	6d4408aa-bd64-4542-a4d1-bb1b4f219b8d	1	2015-10-02

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
Ingredient	Type	UNII	DailyMed label	SPL version
DOCUSATE SODIUM	ACTIVE INGREDIENT	F05Q2T2JA0	SENEXON-S (DOCUSATE SODIUM -SENNOSIDES) TABLET, COATED [AIDAREX PHARMACEUTICALS LLC]	1
SENNOSIDES A AND B	ACTIVE INGREDIENT	1B5FPI42EN	SENEXON-S (DOCUSATE SODIUM -SENNOSIDES) TABLET, COATED [AIDAREX PHARMACEUTICALS LLC]	1
DOCUSATE	ACTIVE MOIETY	M7P27195AG	SENEXON-S (DOCUSATE SODIUM -SENNOSIDES) TABLET, COATED [AIDAREX PHARMACEUTICALS LLC]	1
SENNOSIDES A AND B	ACTIVE MOIETY	1B5FPI42EN	SENEXON-S (DOCUSATE SODIUM -SENNOSIDES) TABLET, COATED [AIDAREX PHARMACEUTICALS LLC]	1
CALCIUM PHOSPHATE, DIBASIC, DIHYDRATE	INACTIVE INGREDIENT	O7TSZ97GEP	SENEXON-S (DOCUSATE SODIUM -SENNOSIDES) TABLET, COATED [AIDAREX PHARMACEUTICALS LLC]	1
CARNAUBA WAX	INACTIVE INGREDIENT	R12CBM0EIZ	SENEXON-S (DOCUSATE SODIUM -SENNOSIDES) TABLET, COATED [AIDAREX PHARMACEUTICALS LLC]	1
CELLULOSE, MICROCRYSTALLINE	INACTIVE INGREDIENT	OP1R32D61U	SENEXON-S (DOCUSATE SODIUM -SENNOSIDES) TABLET, COATED [AIDAREX PHARMACEUTICALS LLC]	1
CROSCARMELLOSE SODIUM	INACTIVE INGREDIENT	M28OL1HH48	SENEXON-S (DOCUSATE SODIUM -SENNOSIDES) TABLET, COATED [AIDAREX PHARMACEUTICALS LLC]	1
D&C YELLOW NO. 10	INACTIVE INGREDIENT	35SW5USQ3G	SENEXON-S (DOCUSATE SODIUM -SENNOSIDES) TABLET, COATED [AIDAREX PHARMACEUTICALS LLC]	1
FD&C YELLOW NO. 6	INACTIVE INGREDIENT	H77VEI93A8	SENEXON-S (DOCUSATE SODIUM -SENNOSIDES) TABLET, COATED [AIDAREX PHARMACEUTICALS LLC]	1
HYPROMELLOSE 2910 (6 MPA.S)	INACTIVE INGREDIENT	0WZ8WG20P6	SENEXON-S (DOCUSATE SODIUM -SENNOSIDES) TABLET, COATED [AIDAREX PHARMACEUTICALS LLC]	1
MAGNESIUM STEARATE	INACTIVE INGREDIENT	70097M6I30	SENEXON-S (DOCUSATE SODIUM -SENNOSIDES) TABLET, COATED [AIDAREX PHARMACEUTICALS LLC]	1
POLYETHYLENE GLYCOLS	INACTIVE INGREDIENT	3WJQ0SDW1A	SENEXON-S (DOCUSATE SODIUM -SENNOSIDES) TABLET, COATED [AIDAREX PHARMACEUTICALS LLC]	1
SILICON DIOXIDE	INACTIVE INGREDIENT	ETJ7Z6XBU4	SENEXON-S (DOCUSATE SODIUM -SENNOSIDES) TABLET, COATED [AIDAREX PHARMACEUTICALS LLC]	1
SODIUM BENZOATE	INACTIVE INGREDIENT	OJ245FE5EU	SENEXON-S (DOCUSATE SODIUM -SENNOSIDES) TABLET, COATED [AIDAREX PHARMACEUTICALS LLC]	1
STEARIC ACID	INACTIVE INGREDIENT	4ELV7Z65AP	SENEXON-S (DOCUSATE SODIUM -SENNOSIDES) TABLET, COATED [AIDAREX PHARMACEUTICALS LLC]	1
TITANIUM DIOXIDE	INACTIVE INGREDIENT	15FIX9V2JP	SENEXON-S (DOCUSATE SODIUM -SENNOSIDES) TABLET, COATED [AIDAREX PHARMACEUTICALS LLC]	1

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDC	Dashboard title	SPL version	Validation	Dashboard ZIP
33261-749	SENEXON-S (DOCUSATE SODIUM -SENNOSIDES) TABLET, COATED [AIDAREX PHARMACEUTICALS LLC]	1	Legacy NDC, 1 package rows	20140106_b3c26587-5b4b-4360-b491-6fde5a908c8b.zip

UNII, Preferred term, Registry number table
UNII	Preferred term	Registry number	Matched term
F05Q2T2JA0	DOCUSATE SODIUM	577-11-7	DOCUSATE SODIUM
1B5FPI42EN	SENNOSIDES A AND B	62211-03-4	SENNOSIDES A AND B

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUI	RxNorm string	TTY	DailyMed	SPL version
1248013	Senexon-S 50 MG / 8.6 MG Oral Tablet	PSN	b3c26587-5b4b-4360-b491-6fde5a908c8b	1
998740	sennosides 8.6 MG / docusate sodium 50 MG Oral Tablet	PSN	b3c26587-5b4b-4360-b491-6fde5a908c8b	1
1248013	docusate sodium 50 MG / sennosides, USP 8.6 MG Oral Tablet [Senexon S]	SBD	b3c26587-5b4b-4360-b491-6fde5a908c8b	1
998740	docusate sodium 50 MG / sennosides, USP 8.6 MG Oral Tablet	SCD	b3c26587-5b4b-4360-b491-6fde5a908c8b	1
998740	DOSS Sodium 50 MG / sennosides, USP 8.6 MG Oral Tablet	SY	b3c26587-5b4b-4360-b491-6fde5a908c8b	1
1248013	DOSS Sodium 50 MG / sennosides, USP 8.6 MG Oral Tablet [Senexon S]	SY	b3c26587-5b4b-4360-b491-6fde5a908c8b	1
1248013	Senexon-S (docusate sodium 50 MG / sennosides, USP 8.6 MG) Oral Tablet	SY	b3c26587-5b4b-4360-b491-6fde5a908c8b	1

Packages#

Package NDC, 11-digit format, Description table
Package NDC	11-digit format	Description	Status
33261-749-00	33261074900	100 in 1 BOTTLE, PLASTIC	Historical

Title, Manufacturer, Effective date table
Title	Manufacturer	Effective date	Type	Version
DOCUSATE SOD SENNA 50 8 6MG FOR RUGBY	Aidarex Pharmaceuticals LLC	2013-12-30	HUMAN OTC DRUG LABEL	1